8 results about "Lauromacrogol" patented technology

The application belongs to the technical field of medicine, and relates to a medicine and instrument combination system for treating bromhidrosis by using a sclerosing agent and a multi-needle injection needle and application thereof. The medicine and instrument combination system is a medicine and instrument composition comprising a sclerosing agent and a disposable sterile injection needle. The sclerosing agent comprises one or more of polidocanol, lauromacrogol, sodium myristyl sulfate and sodium morrhuate. The disposable sterile injection needle is a nine-needle injection needle or a five-needle injection needle. The nine-needle injection needle or the five-needle injection needle has uniformly distributed needle heads and equal lengths of the needle heads. The medicine and instrument combination system can standardize injection of the sclerosing agent in the process of treating bromhidrosis, accurately control the dosage, control the curative effect, reduce adverse reactions and improve safety.

To provide a composition for external use excellent in low-temperature stability, especially capable of suppressing precipitation at low temperature.SOLUTION: The composition for external use includes an acyl methyl taurine salt and at least one precipitation inhibitor selected from lauromacrogol, lauric acid diethanolamide, and lauryl dimethylamine oxide.SELECTED DRAWING: None

The present application belongs to the field of pharmaceutical preparations, and particularly relates to an injectable temperature-sensitive gel foam sclerosing agent. The injectable temperature-sensitive gel foam sclerosing agent comprises lauromacrogol air foam and poloxamer 407, and is a new treatment strategy formed by combining the advantages of foam sclerosing agents and temperature-sensitive gels. In the process of compounding components, it is accidentally found that, under the synergistic effect of specific concentrations and components, lauromacrogol is the main foaming agent, poloxamer 407 is attached to the liquid film surface layer of the foam, the foam volume is basically unchanged, and the poloxamer 407 and lauromacrogol air foam are mutually synergistic, the stability of the foam is increased, and the action time of the drug at the lesion site is significantly prolonged.

The utility model relates to a laser ablation and injection, flushing and puncture combined guide auxiliary treatment handle, which belongs to the technical field of laser ablation and comprises a guide needle body, the guide needle body comprises an optical fiber front catheter and an injection front catheter, and the outer side of the optical fiber front catheter is connected with the outer side of the injection front catheter; the outer side of the optical fiber front guide pipe is sleeved with an optical fiber guide pipe in a clamped mode, and the optical fiber guide pipe and the optical fiber front guide pipe are coaxial. A puncture point is determined through ultrasonic probing of the size of a focus, one end of the guide needle body is punctured into a focus vascular cavity under ultrasonic guidance, the laser optical fiber sequentially penetrates through the optical fiber catheter and the optical fiber front catheter, one end of the laser optical fiber is moved into the focus vascular cavity for ablation, and then the needle head is used for sucking hematocele in the focus. And lauromacrogol foam is prepared, the lauromacrogol foam is injected into the injection tube from the threaded inlet by using an injector, and the lauromacrogol foam is injected into the focus by the injection tube for hardening injection embolism, so that the optimal treatment effect is achieved, and the treatment frequency is reduced.

Provided are: an inkjet ink for a solid preparation, the inkjet ink having exceptional dischargeability from a nozzle of an inkjet head when applied using an inkjet method; a solid preparation; and a method for producing a solid preparation. An inkjet ink for a solid preparation according to the present invention contains ethanol that serves as the main solvent, an active ingredient that is soluble in ethanol, and a viscosity adjuster that adjusts the viscosity of the inkjet ink for a solid preparation, the viscosity modifier being at least one selected from the group consisting of polyoxyethylene sorbitan monolaurate, polyoxyethylene sorbitan monopalmitate, polyoxyethylene sorbitan monostearate, polyethylene glycol sorbitan monooleate, polyethylene glycol, lauromacrogol, polyvinylpyrrolidone having a K value of 25 or lower, and shellac.

The invention provides a gastric fundus varicosity treatment method, which relates to the technical field of medical treatment, and comprises the following steps: step 1, preparing an injection assembly, a three-way auxiliary device with an integrated structure, a first injector containing assembly glue and a second injector containing lauromacrogol, the injection assembly, the first injector and the second injector are respectively mounted at three connecting ports of the three-way employer auxiliary device, and one-way valves are arranged at the positions where the first injector and the second injector are connected; 2, anesthetizing a patient before entering the endoscope, checking and confirming a bleeding part and an esophageal and gastric fundus varicose vein rupture bleeding type after anesthesia is completed, then selecting an injection point, and vertically inserting a needle; 3, the medical staff injects 3.0 ml to 4.0 ml of lauromacrogol injection liquid, 0.5 ml to 1.0 ml of medical glue and 3.0 ml to 4.0 ml of lauromacrogol injection liquid in sequence; 4, after injection is completed, the injection needle is withdrawn, whether the varicose vein becomes hard or not is checked, and if residual veins do not become hard or bleeding completely, multi-point repeated injection can be conducted till the varicose vein becomes hard completely.

The invention relates to the technical field of medicine, and particularly discloses a foam hardening agent for treating low-flow-rate vascular malformation and a preparation method thereof, the foam hardening agent comprises a drug conjugate, a stabilizer, a water-soluble enhancer, foaming gas and an injection solvent; according to the drug conjugate, citric anhydride is bridged with lauromacrogol and bleomycin to form a covalent structure, so that the problems of non-uniform drug distribution and poor synergism during physical mixing are solved. The preparation method comprises the following steps: synthesizing a conjugate through esterification and amidation reactions, mixing the conjugate with auxiliary materials, and foaming through a Tesari method. The two drugs are bridged through the citric anhydride to form a conjugate which can be synergistically slowly released in a focus microenvironment, the curative effect is remarkably improved, meanwhile, the single drug dosage and toxic and side effects are reduced, and the foam preparation is high in stability, clear in development and suitable for precise interventional therapy guided by color ultrasound.

The utility model discloses a K type cross two-way interface for hardening treatment of esophageal and gastric fundus varicose veins, which relates to the technical field of pipe connecting components and comprises a first through pipe, a conversion cavity is arranged at one end of the first through pipe, a fourth through pipe is arranged at the other end of the conversion cavity, a second through pipe is arranged on one side of the conversion cavity, and a third through pipe is arranged on the other side of the second through pipe. A conversion plate is arranged in the conversion cavity and composed of a first gate plate, a second gate plate, a third gate plate and a fourth gate plate, the first gate plate and the fourth gate plate are oppositely arranged, the included angle between the second gate plate and the third gate plate is 90 degrees, and the included angle between the second gate plate and the fourth gate plate is 45 degrees. The included angle between the first gate plate and the second gate plate is 45 degrees. By arranging a series of structures, the lauromacrogol injection, the tissue glue injection and the 50% glucose injection can be respectively injected without pulling and inserting the liquid injection tube, so that the liquid medicine injection efficiency is improved, and the leakage risk is reduced.